Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 60

Results For "SPI"

2272 News Found

Health Minister Nadda reviews Monkeypox situation and preparedness
Policy | August 19, 2024

Health Minister Nadda reviews Monkeypox situation and preparedness

Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management


Health Ministry assures doctors of all possible efforts to ensure safety
Policy | August 19, 2024

Health Ministry assures doctors of all possible efforts to ensure safety

A committee to be formed to suggest measures for ensuring the safety of healthcare professionals


CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance
News | August 19, 2024

CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance

The emergence of new infections in India is a growing concern


Pfizer and BioNTech update on mRNA-based combination vaccine program against Influenza and Covid-19
News | August 16, 2024

Pfizer and BioNTech update on mRNA-based combination vaccine program against Influenza and Covid-19

In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives


HCAH Kolkata Center achieves NABH Certification
News | August 15, 2024

HCAH Kolkata Center achieves NABH Certification

Becomes the first rehab & recovery center in east India to earn NABH accreditation


NHA and MUHS sign MoU to drive digital health education
News | August 14, 2024

NHA and MUHS sign MoU to drive digital health education

The partnership marks a significant milestone in integrating digital health education into medical curricula


HealthCRED secures US$ 1.2 million in seed funding
Startup | August 13, 2024

HealthCRED secures US$ 1.2 million in seed funding

The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service


Pfizer announces results of ABRYSVO for RSV in immunocompromised adults
Diagnostic Center | August 13, 2024

Pfizer announces results of ABRYSVO for RSV in immunocompromised adults

These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV


Enhertu approved in China for patients with previously treated HER2-positive advanced or metastatic gastric cancer
Drug Approval | August 13, 2024

Enhertu approved in China for patients with previously treated HER2-positive advanced or metastatic gastric cancer

Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years


Zydus Lifesciences Q1 FY25 revenue up 21% YoY to reach Rs. 6,207.5 Cr
News | August 11, 2024

Zydus Lifesciences Q1 FY25 revenue up 21% YoY to reach Rs. 6,207.5 Cr

Research & Development (R&D) investments for the quarter stood at Rs. 392.5 crore which is 6.3% of its revenues